Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Goldsweig and Gregory Valania.
Connection Strength
0.939
-
Saad AM, Eid F, Abozenah M, Valania GE, Goldsweig AM. In-hospital outcomes of sepsis hospitalizations among patients with cardiac amyloidosis: A 2022 National inpatient sample analysis. Curr Probl Cardiol. 2026 Oct; 51(10):103404.
Score: 0.248
-
Jain H, Patel N, Soni K, Shuja MH, Jain J, Agrawal SP, Ahmed M, Valania G, Salerno C, Goldsweig AM. Glucagon-like Peptide-1 Receptor Agonist Use and Outcomes in Peripartum Cardiomyopathy: A Propensity-Score Matched Analysis. Can J Cardiol. 2026 Apr; 42(4):843-846.
Score: 0.239
-
Ezenna C, Valania G, Goldsweig AM. Editorial: Cardiac amyloidosis: To prevent arrhythmia, treat before it's too late. Cardiovasc Revasc Med. 2026 Jan; 82:100-101.
Score: 0.228
-
Ezenna C, Krishna MM, Joseph M, Pereira V, Nadeem S, Valania G, Goldsweig AM. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2025 Apr 15; 241:52-60.
Score: 0.224